
Comparison of bare metal stent with pioglitazone versus sirolimus-eluting stent for percutaneous coronary intervention in patients with Type 2 diabetes mellitus
Keywords: Bare metal stent; Major adverse cardiac events; Pioglitazone; Restenosis; Sirolimus-eluting stent